Gifu, Japan

Masaru Sato

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tsujimoto Kagaku Kogyo Co., Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaru Sato. Retrieved from https://idiyas.com/inventor/masaru-sato-tgjyxc5a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaru Sato: Innovator in Anti-MRSA Compounds

Introduction

Masaru Sato is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that combat antibiotic-resistant bacteria. His work is crucial in addressing the growing concern of methicillin-resistant Staphylococcus aureus (MRSA).

Latest Patents

Masaru Sato holds a patent for an anti-MRSA compound. This compound is characterized by a specific formula extracted from the root of Sophora exigua. The primary application of this compound is to treat infections caused by methicillin-resistant Staphylococcus aureus, which poses a serious health risk globally.

Career Highlights

Sato is associated with Tsujimoto Kagaku Kogyo Co., Ltd., where he has been instrumental in research and development. His innovative approach has led to advancements in the pharmaceutical industry, particularly in creating effective treatments for resistant bacterial strains.

Collaborations

Some of his notable coworkers include Munekazu Iinuma and Hironori Tsuchiya. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Masaru Sato's work in developing anti-MRSA compounds highlights the importance of innovation in the fight against antibiotic resistance. His contributions are vital for advancing medical treatments and improving public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…